US2005131034A1PendingUtilityA1

Compounds capable of activating cholinergic receptors

58
Priority: Jun 16, 1998Filed: Feb 1, 2005Published: Jun 16, 2005
Est. expiryJun 16, 2018(expired)· nominal 20-yr term from priority
Inventors:William Scott CaldwellGary Maurice DullBalwinder Singh BhattiSrishailkumar B. HadimaniHaeil ParkJared Miller WagnerPeter A. Crooks
C07D 239/26A61P 25/14C07D 213/61A61P 25/16A61K 31/505C07D 213/65C07D 213/73A61P 25/28A61P 25/18C07D 213/38A61K 31/44C07D 239/24
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Compounds incorporating aryl substituted olefinic amine are provided. Representative compounds are (4E)-N-methyl-5-(3-pyridyl)4-penten-2-amine, (4E)-N-methyl-5-(5-pyrimidinyl)4-penten-2-amine, (4E)-N-methyl-5-(5-methoxy-3-pyridyl)-4-penten-2-amine, (4E)-N-methyl-5-(6-amino-5-methyl-3-pyridyl)-4-penten-2-amine, (2R)-(4E)-N-methyl-5-(3-pyridyl)-4-penten-2-amine, (2R)-(4E)-N-methyl-5-(5-isopropoxy-3-pyridyl)-4-penten-2-amine, (4E)-N-methyl-5-(5-bromo-3-pyridyl)-4-penten-2-amine, (4E)-N-methyl-5-(5-ethoxy-3-pyridyl)-4-penten-2-amine, (2S)-(4E)-N-methyl-5-(3-pyridyl)-4-penten-2-amine, (4E)-N-methyl-5-(5-isopropoxy-3-pyridyl)-4-penten-2-amine and (2S)-(4E)-N-methyl-5-(5-isopropoxy-3-pyridyl)-4-penten-2-amine.

Claims

exact text as granted — not AI-modified
1 . A compound selected from the group consisting of (2S)-(4E)-N-methyl-5-(5-isopropoxy-3-pyridyl)-4-penten-2-amine and (2R)-(4E)-N-methyl-5-(5-isopropoxy-3-pyridyl)-4-penten-2-amine.  
     
     
         2 . A compound denoted (2S)-(4E)-N-methyl-5-(5-isopropoxy-3-pyridyl)-4-penten-2-amine.  
     
     
         3 . A compound denoted (2R)-(4E)-N-methyl-5-(5-isopropoxy-3-pyridyl)-4-penten-2-amine.  
     
     
         4 . The hemigalactarate salt of the compound of  claim 2 .  
     
     
         5 . The hemigalactarate salt of the compound of  claim 3.

Join the waitlist — get patent alerts

Track US2005131034A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.